for King County Bar Association
1. Amgen Inc. v. F. Hoffmann-La Roche, Ltd., 2009-1020, -1096, UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT, September 15, 2009, Decided
OVERVIEW: District court erred when it concluded that the safe harbor protections of 35 U.S.C.S. § 121 shielded certain product patents from invalidity resulting from obviousness-type double patenting because in this case the applications descended from continuation applications exclusively, and not from divisional applications.
If you are not a registered lexisONE® Community user, you will be asked to register.
Registration is free.